HOME Press Releases Fertility Test Market worth 583.1 million USD by 2023



Fertility Test Market worth 583.1 million USD by 2023


The report "Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023", The global fertility test market is expected to reach USD 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%. The major factors driving the growth of the fertility test market include declining fertility rates across the globe, increasing first-time pregnancy age, introduction of advanced, user-friendly fertility monitors with high accuracy.

                                   Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 71 market data Tables and 31 Figures spread through 140 Pages and in-depth TOC on "Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023"
https://www.marketsandmarkets.com/Market-Reports/fertility-testing-devices-market-139945432.html
Early buyers will receive 10% customization on reports.

The ovulation predictor kits segment accounted for the largest share of the market by product in 2018

The fertility test market is segmented on the basis of product into ovulation predictor kits, fertility monitors, and male fertility testing products. The fertility monitors segment is further categorized into urine-based, saliva-based and other fertility monitors. The ovulation predictor kits segment commanded the largest share of the global fertility test market in 2018. This is primarily due to their low cost and high efficacy, high preference for these products, ease of use, low cost as compared to fertility monitors, and easy OTC availability.

Non-Prescription/OTC based is expected to account for a larger share of the market by mode of purchase in 2018

Based on the mode of purchase, the global fertility test market is classified into segments prescription-based and non-prescription/OTC-based. The non-prescription/OTC-based segment is expected to account for a larger share of the fertility test market in 2018 due to its inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, easy availability, and use of fertility and ovulation monitors on e-commerce websites.

North America is expected to dominate the fertility test market during the forecast period.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global fertility test market during the forecast period (2018-2023). The large share can be attributed to the growing use of fertility monitoring devices for contraception and rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites. In addition, the emergence of advanced easy-to-use fertility monitors with high accuracy is one of the key factors propelling the growth of the fertility test market in North America.

The major players operating in the fertility test market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings, Inc. (US), among others.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

We will organize an analyst call and demonstrate the latent opportunities and threats which will likely impact your business, at no cost.

Speak to Analyst


* Name :
* Business Email :
* Phone :
* Designation :
* Country:
Report MD 4215: Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023
* Enter the text from the image
   to the textbox :
9 2 0 7 8  
Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports